+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cilazapril Market by Application, Form, Distribution Channel, Dosage Strength, End User - Global Forecast to 2030- Product Image
Cilazapril Market by Application, Form, Distribution Channel, Dosage Strength, End User - Global Forecast to 2030- Product Image
Sale

Cilazapril Market by Application, Form, Distribution Channel, Dosage Strength, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977785
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cilazapril market is evolving rapidly, shaped by significant advancements in cardiovascular therapeutics, regulatory changes, and emerging clinical practices. This market overview provides senior decision-makers with actionable insights into the sector’s drivers, constraints, and strategic imperatives, ensuring informed decisions in a complex healthcare landscape.

Market Snapshot: Cilazapril Market Trends and Growth

In recent years, the cilazapril market has demonstrated steady growth, driven by rising global demand for effective hypertension and heart failure therapies. The sector is advancing at a compound annual growth rate that reflects both demographic shifts and evolving treatment protocols. Senior leaders should note the strategic importance of cilazapril as a reliable angiotensin-converting enzyme inhibitor across acute and chronic cardiovascular care settings. Increasing epidemiological pressures, coupled with a competitive landscape influenced by generics and new entrants, are shaping market trajectories worldwide.

Scope & Segmentation

This analysis offers detailed segmentation covering multiple facets of cilazapril’s market exposure. Strategic targeting and operational alignment are enabled by an understanding of these sub-categories:

  • Therapeutic Applications: Heart failure; all stages of hypertension management (stage 1, stage 2, stage 3).
  • Formulation Types: Capsule, oral solution, oral suspension, tablet—each designed for distinct patient preferences and clinical requirements.
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy.
  • Dosage Strengths: 5 mg and 10 mg dosages tailored to titration and patient needs.
  • End User Settings: Clinics, home care, hospitals encompassing varied models of care delivery.
  • Regional Markets:
    • Americas: United States (including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Key Market Participants: Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Viatris Inc., Sun Pharmaceutical Industries Ltd., Lupin Limited, Cipla Limited, Dr. Reddy's Laboratories Limited, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Alembic Pharmaceuticals Limited.

Key Takeaways for Decision-Makers

  • Personalized medicine and pharmacogenomic profiling are reshaping clinical protocols, allowing tailored dosing and enhanced patient outcomes.
  • Digital health platforms are becoming integral, enabling real-time monitoring, improved adherence, and data-driven optimization of therapy.
  • Demand for alternative formulations, such as oral solutions and suspensions, is growing in sub-populations like pediatrics and geriatrics who face challenges with traditional capsules or tablets.
  • Supply chain resilience has risen in strategic importance, with manufacturers increasingly localizing and diversifying production capabilities to respond to external risks.
  • Competitive intensity from generic entrants is escalating, necessitating robust real-world evidence and innovative partnerships to maintain market position.
  • Regional heterogeneity in reimbursement, regulatory frameworks, and clinical adoption necessitates locally informed market entry and access strategies.

Cilazapril Market: Tariff Impact on Supply Chain

In 2025, enhanced tariffs affected global cilazapril supply chains, altering end-to-end cost structures. Manufacturers restructured supplier agreements and leveraged production in tariff-exempt regions to counteract heightened expense pressures. Distributors and healthcare providers faced shifts in procurement costs, prompting more stringent rebate negotiations. This development led stakeholders to accelerate diversification, enhance price strategies, and reevaluate sourcing—especially in price-sensitive regions reliant on public health programs.

Methodology & Data Sources

This report applies a multi-tiered research framework, combining primary interviews with industry leaders, clinicians, and executives with secondary data from peer-reviewed journals, regulatory filings, and proprietary databases. Robust cross-verification and quantitative validation ensure the credibility and applicability of all insights, aligning each recommendation with real-world cilazapril market dynamics. Regional and segmental coverage is comprehensive, guided by current best practices.

Why This Report Matters

  • Enables strategic planning by providing granular segmentation and regional market intelligence for targeted investments.
  • Gives executives a clear reference for navigating regulatory, competitive, and clinical landscape challenges in cardiovascular therapeutics.
  • Equips stakeholders with actionable guidance to adapt to supply chain changes and position for sustained market leadership.

Conclusion

The cilazapril market’s evolving dynamics offer both opportunities and challenges. Stakeholders who prioritize data-driven decision-making and operational agility will be best poised to capture long-term value and resilience amid ongoing shifts in global cardiovascular care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of hypertension and heart conditions
5.1.1.2. Growing geriatric population across countries
5.1.2. Restraints
5.1.2.1. Product recall and side effects associated with cilazapril
5.1.3. Opportunities
5.1.3.1. Enhanced funding and infrastructure improvements in healthcare
5.1.3.2. Combination therapies to enhance drug efficacy
5.1.4. Challenges
5.1.4.1. Availability of alternative treatments
5.2. Market Segmentation Analysis
5.2.1. Formulation: Extensive usage of cilazapril hydrochloride formulation to enhance medication’s solubility and stability
5.2.2. Application: Expanding consumption of cilazapril drugs to lower high blood pressure, prevent heart attacks, and kidney problems
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cilazapril Market, by Formulation
6.1. Introduction
6.2. Cilazapril Hydrochloride
6.3. Cilazapril Monohydrate
7. Cilazapril Market, by Form
7.1. Introduction
7.2. Capsules
7.3. Tablets
8. Cilazapril Market, by Application
8.1. Introduction
8.2. Heart Failure Management
8.3. Hypertension Management
9. Cilazapril Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Offline Retail Pharmacies
9.4. Online Pharmacies
10. Americas Cilazapril Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cilazapril Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cilazapril Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Lupin Secures USFDA Approval for Generic Cilazapril
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CILAZAPRIL MARKET RESEARCH PROCESS
FIGURE 2. CILAZAPRIL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CILAZAPRIL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CILAZAPRIL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CILAZAPRIL MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CILAZAPRIL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CILAZAPRIL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CILAZAPRIL MARKET DYNAMICS
TABLE 7. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL MONOHYDRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CILAZAPRIL MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CILAZAPRIL MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CILAZAPRIL MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CILAZAPRIL MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CILAZAPRIL MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CILAZAPRIL MARKET SIZE, BY OFFLINE RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CILAZAPRIL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. CANADA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 34. CANADA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 35. CANADA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. MEXICO CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 38. MEXICO CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 39. MEXICO CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. CHINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 56. CHINA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 57. CHINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. INDIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 60. INDIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 61. INDIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. JAPAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 68. JAPAN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 69. JAPAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. THAILAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 92. THAILAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 93. THAILAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 105. DENMARK CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 106. DENMARK CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. DENMARK CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. EGYPT CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 109. EGYPT CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 110. EGYPT CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. FINLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 113. FINLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 114. FINLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. FRANCE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 117. FRANCE CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. GERMANY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 121. GERMANY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. GERMANY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. ITALY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 129. ITALY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 130. ITALY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. NORWAY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 141. NORWAY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 142. NORWAY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. POLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 145. POLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 146. POLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. QATAR CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 149. QATAR CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 150. QATAR CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SPAIN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 165. SPAIN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 166. SPAIN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. TURKEY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 177. TURKEY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 178. TURKEY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. CILAZAPRIL MARKET SHARE, BY KEY PLAYER, 2023
TABLE 189. CILAZAPRIL MARKET, FPNV POSITIONING MATRIX, 2023

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cilazapril market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Limited
  • Aurobindo Pharma Limited
  • Hikma Pharmaceuticals PLC
  • Alembic Pharmaceuticals Limited

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 264.57 Million
Forecasted Market Value ( USD ) by 2030 $ 339.56 Million
Compound Annual Growth Rate5.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cilazapril (CAS 88768-40-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Cilazapril (CAS 88768-40-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Hypertension Drug Market by Dosage Form, Age Group, Treatment Type, Distribution Channel, End User, Drug Class - Global Forecast to 2030 - Product Image

Hypertension Drug Market by Dosage Form, Age Group, Treatment Type, Distribution Channel, End User, Drug Class - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Clonidine Market by Product Form, Indication, Distribution Channel, End User, Route of Administration, Dosage Strength - Global Forecast to 2030 - Product Image

Clonidine Market by Product Form, Indication, Distribution Channel, End User, Route of Administration, Dosage Strength - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Telmisartan Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2025-2034) - Product Image

Telmisartan Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Intracranial Aneurysm Market Size, Share & Trends Analysis Report by Type, (Surgical Clipping, Endovascular Coiling, Flow Diverters), End-use (Hospitals, Clinics), Region, with Growth Forecasts, 2025-2030 - Product Image

Intracranial Aneurysm Market Size, Share & Trends Analysis Report by Type, (Surgical Clipping, Endovascular Coiling, Flow Diverters), End-use (Hospitals, Clinics), Region, with Growth Forecasts, 2025-2030

  • Report
  • 110 Pages
  • Global
From

About the Cilazapril Market

Cilazapril is a cardiovascular drug used to treat hypertension and congestive heart failure. It is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of a hormone that causes blood vessels to narrow. This helps to reduce blood pressure and improve the flow of blood to the heart. Cilazapril is usually taken once a day, with or without food. It is available in tablet form and is usually taken in combination with other medications. Cilazapril is a widely used drug in the cardiovascular market, with many generic and branded versions available. It is often prescribed as a first-line treatment for hypertension, and is also used to treat congestive heart failure. It is generally well-tolerated, with few side effects. Some companies that produce cilazapril include Pfizer, Novartis, Merck, and Mylan. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.